Dariusz Pytel to Alzheimer Disease
This is a "connection" page, showing publications Dariusz Pytel has written about Alzheimer Disease.
Connection Strength
0.435
-
[Niskoczasteczkowe inhibitory szlaku adaptacyjnej odpowiedzi na stres zaleznego od kinazy PERK jako nowatorska strategia terapeutyczna w leczeniu choroby Alzheimera]. Pol Merkur Lekarski. 2019 Jan 28; 46(271):9-15.
Score: 0.113
-
Inhibition of the PERK-Dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer's Disease. Curr Alzheimer Res. 2019; 16(3):209-218.
Score: 0.112
-
[Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment]. Pol Merkur Lekarski. 2016 Jul 29; 41(241):5-10.
Score: 0.095
-
Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease. Curr Med Chem. 2015; 22(27):3169-84.
Score: 0.085
-
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases. Int J Mol Sci. 2020 Mar 19; 21(6).
Score: 0.030